Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2199-2214

  Mostofsky, Elizabeth ^a,b   Lipsitch, Marc ^a   Regev yochay, Gili ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

Bacterial resistance; Community associated infections; Healthcare associated infections; Staphylococcal infections

Indexed keywords

ANTIBIOTIC AGENT; PANTON VALENTINE LEUKOCIDIN;

AGE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BLOODSTREAM INFECTION; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; DISEASE SURVEILLANCE; EPIDEMIC; HEALTHCARE ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MALE HOMOSEXUAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT CARE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80052908171     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr278     Document Type: Article

References (101)

1. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71.
2. Wertheim HF, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-62.
3. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
4. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol 2008; 8: 747-63.
5. Strommenger B, Braulke C, Heuck D et al. spa typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol 2008; 46: 574-81.
6. Grundmann H, Aires-de-Sousa M, Boyce J et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-85.
7. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13: 1840-6.
8. Dall'Antonia M, Coen PG, Wilks M et al. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J Hosp Infect 2005; 61: 62-7.
9. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 2000; 97: 1938-43.
10. Shinefield HR, Ribble JC, Boris M et al. Bacterial interference between strains of S. aureus. Ann NY Acad Sci 1974; 236: 444-55.
11. Maldonado G, Greenland S. Estimating causal effects. Int J Epidemiol 2002; 31: 422-9.
12. Chang FY, Peacock JE Jr, Musher DM et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003; 82: 333-9.
13. Stryjewski ME, Szczech LA, Benjamin DK Jr et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44: 190-6.
14. Colijn C, Cohen T, Fraser C et al. What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface 2010; 7: 905-19.
15. Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197: 1226-34.
16. Jevons MP. " Celbenin" -resistant staphylococci. Br Med J 1961; i: 124-5.
17. Panlilio AL, Culver DH, Gaynes RP et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-6.
18. Boyce JM, Jackson MM, Pugliese G et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections within Hospitals. Infect Control Hosp Epidemiol 1994; 15: 105-15.
19. Klevens RM, Edwards JR, Tenover FC et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42: 389-91.
20. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005; 56: 455-62.
21. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7: 178-82.
22. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97: 309-17.
23. Linnemann CC Jr, Mason M, Moore P et al. Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol 1982; 115: 941-50.
24. Spindel SJ, Strausbaugh LJ, Jacobson C. Infections caused by Staphylococcus aureus in a Veterans' Affairs nursing home care unit: a 5-year experience. Infect Control Hosp Epidemiol 1995; 16: 217-23.
25. Albertini MT, Benoit C, Berardi L et al. Surveillance of methicillinresistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum b-lactamase (ESBLE) in northern France: a five-year multicentre incidence study. J Hosp Infect 2002; 52: 107-13.
26. Pavillard R, Harvey K, Douglas D et al. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1982; 1: 451-4.
27. Boyce JM, White RL, Spruill EY. Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J Infect Dis 1983; 148: 763.
28. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9: 891-907.
29. Tam AY, Yeung CY. The changing pattern of severe neonatal staphylococcal infection: a 10-year study. Aust Paediatr J 1988; 24: 275-9.
30. Stamm AM, Long MN, Belcher B. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 1993; 21: 70-4.
31. Pujol M, Pena C, Pallares R et al. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13: 96-102.
32. Jernigan JA, Clemence MA, Stott GA et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995; 16: 686-96.
33. Speller DC, Johnson AP, James D et al. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-5.
34. Morgan M, Salmon R, Evans-Williams D et al. Resistance to methicillin in isolates of Staphylococcus aureus from blood and cerebrospinal fluid in Wales, 1993-1997. J Antimicrob Chemother 1999; 44: 541-4.
35. Assadian O, Daxboeck F, Aspoeck C et al. National surveillance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Austrian hospitals: 1994-1998. J Hosp Infect 2003; 55: 175-9.
36. Seal JB, Moreira B, Bethel CD et al. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol 2003; 24: 403-8.
37. Law MR, Gill ON. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect 1988; 101: 623-9.
38. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009; 48: 910-3.
39. Rodríguez-Baño J, Garcia L, Ramirez E et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol 2010; 31: 786-95.
40. Whyte D, Monahan R, Boyle L et al. The incidence of S. aureus bacteraemia in acute hospitals of the Mid-Western Area, Ireland, 2002-2004. Euro Surveill 2005; 10: pii=538.
41. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
42. Anderson DJ, Sexton DJ, Kanafani ZA et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28: 1047-53.
43. van der Mee-Marquet N, Epinette C, Loyau J et al. Staphylococcus aureus strains isolated from bloodstream infections changed significantly in 2006. J Clin Microbiol 2007; 45: 851-7.
44. Allard C, Carignan A, Bergevin M et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect 2008; 14: 421-8.
45. Burton DC, Edwards JR, Horan TC et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009; 301: 727-36.
46. Hacek DM, Paule SM, Thomson RB Jr et al. Implementation of a universal admission surveillance and decolonization program for methicillin-resistant Staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory. J Clin Microbiol 2009; 47: 3749-52.
47. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009; 64 Suppl 1: i11-7.
48. Chen H, Liu Y, Jiang X et al. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother 2010; 54: 1842-7.
49. Wilson J, Elgohari S, Livermore DM et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2011; 17: 451-8.
50. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25: 97-108.
51. CDC. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 1999; 282: 1123-5.
52. CDC. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 88.
53. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-44.
54. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7: 629-41.
55. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
56. Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010; 10: 227-39.
57. Jarvis WR, Schlosser J, Chinn RY et al. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007; 35: 631-7.
58. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74.
59. Zetola N, Francis JS, Nuermberger EL et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5: 275-86.
60. Deleo FR, Otto M, Kreiswirth BN et al. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375: 1557-68.
61. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
62. David MZ, Glikman D, Crawford SE et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197: 1235-43.
63. Robinson JO, Pearson JC, Christiansen KJ et al. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2009; 28: 353-61.
64. Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006; 6: 753-5.
65. Chuang YC, Chen YC, Chang SC et al. Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007. J Hosp Infect 2010; 76: 143-9.
66. Yang ES, Tan J, Eells S et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2010; 16: 425-31.
67. Mertz D, Frei R, Periat N et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009; 169: 172-8.
68. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ 2005; 331: 992.
69. Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-91.
70. McCaig LF, McDonald LC, Mandal S et al. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006; 12: 1715-23.
71. Arnold SR, Elias D, Buckingham SC et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop 2006; 26: 703-8.
72. Fortunov RM, Hulten KG, Hammerman WA et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118: 874-81.
73. Manzur A, Vidal M, Pujol M et al. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect 2007; 66: 135-41.
74. Hota B, Ellenbogen C, Hayden MK et al. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med 2007; 167: 1026-33.
75. Hersh AL, Chambers HF, Maselli JH et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585-91.
76. Pallin DJ, Egan DJ, Pelletier AJ et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008; 51: 291-8.
77. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-43.
78. Dailiana ZH, Rigopoulos N, Varitimidis SE et al. Clinical and epidemiological features of upper-extremity infections caused by Staphylococcus aureus carrying the PVL gene: a four-year study in Greece. Med Sci Monit 2008; 14: CR511-4.
79. Price CS, Williams A, Philips G et al. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008; 466: 2842-7.
80. Tattevin P, Diep BA, Jula M et al. Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility. Emerg Infect Dis 2009; 15: 953-5.
81. Orscheln RC, Hunstad DA, Fritz SA et al. Contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis 2009; 49: 536-42.
82. Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies-what are we missing? Nat Rev Microbiol 2004; 2: 979-83.
83. Spiegelhalter DJ. Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus. BMJ 2005; 331: 1013-5.
84. Meyer E, Schwab F, Pollitt A et al. Resistance rates in ICUs: interpretation and pitfalls. J Hosp Infect 2007; 65: 84-5.
85. Shardell M, Harris AD, El-Kamary SS et al. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007; 45: 901-7.
86. Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect 2009; 137: 1665-73.
87. Laupland KB, Ross T, Pitout JD et al. Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin Invest Med 2007; 30: E159-66.
88. Cooper B, Lipsitch M. The analysis of hospital infection data using hidden Markov models. Biostatistics 2004; 5: 223-37.
89. Huang SS, Avery TR, Song Y et al. Quantifying interhospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol 2010; 31: 1160-9.
90. Lee SO, Cho YK, Kim SY et al. Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient. J Clin Microbiol 2004; 42: 4776-9.
91. Verhoef J, Fluit A. Surveillance uncovers the smoking gun for resistance emergence. Biochem Pharmacol 2006; 71: 1036-41.
92. Rosenthal VD, Maki DG, Mehta A et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008; 36: 627-37.
93. Benfield T, Espersen F, Frimodt-Moller N et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-63.
94. Tiemersma EW, Bronzwaer SL, Lyytikainen O et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-34.
95. Kuehnert MJ, Hill HA, Kupronis BA et al. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 2005; 11: 868-72.
96. Lyytikäinen O, Ruotsalainen E, Jarvinen A et al. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005; 24: 399-404.
97. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 2006; 103: 5620-5.
98. Harbarth S, Albrich W, Goldmann DA et al. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis 2001; 1: 251-61.
99. Ender M, McCallum N, Adhikari R et al. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48: 2295-7.
100. Paul J. Surveillance and management of all types of Staphylococcus aureus bacteraemia. BMJ 2006; 333: 269-70.
101. Robicsek A, Beaumont JL, Paule SM et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148: 409-18.